Compară metode
Examinează metodele selectate una lângă alta; rândurile care diferă sunt evidențiate.
| Citometrie de masă imagistică× | Angiografie OCT× | |
|---|---|---|
| Domeniu | Imagistică medicală | Imagistică medicală |
| Familie | Process / pipeline | Process / pipeline |
| Anul apariției≠ | 2014 | 2012 |
| Autorul original≠ | Bernd Bodenmiller | Yali Jia |
| Tip≠ | Multiplexed single-cell imaging by mass spectrometry | Optical imaging technique for vasculature visualization |
| Sursa seminală≠ | Giesen, C., Wang, H. A., Schapiro, D., et al. (2014). Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nature Methods, 11(4), 417-422. DOI ↗ | Jia, Y., Tan, O., Tokayer, J., et al. (2012). Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Optics Express, 20(4), 4710-4725. DOI ↗ |
| Denumiri alternative≠ | IMC, mass cytometry, multiplex ion beam imaging, MIBI | OCTA, OCT-A |
| Înrudite | 5 | 5 |
| Rezumat≠ | Imaging Mass Cytometry (IMC) is a multiplexed proteomics technique that maps the subcellular localization of up to 40-50 proteins in tissue sections simultaneously using mass spectrometry detection. Developed by Bodenmiller and colleagues in 2014, IMC combines the single-cell imaging power of immunofluorescence with the multiplexing capacity of mass cytometry, enabling comprehensive analysis of cell types, states, and spatial interactions within tissue microenvironments. IMC has emerged as a powerful tool in immuno-oncology, immunobiology, and tissue biology for dissecting cellular heterogeneity and spatial organization. | Optical Coherence Tomography Angiography (OCTA) is a non-invasive imaging technique that visualizes the microvasculature in the retina and choroid by detecting motion contrast from flowing blood. Developed by Jia and colleagues in 2012, OCTA uses repeated OCT scans of the same tissue location to identify blood flow based on the decorrelation signal. It has become a critical diagnostic tool in ophthalmology for detecting retinal and macular diseases without requiring fluorescein injection. |
| ScholarGateSet de date ↗ |
|
|